Health Current Affairs, GK & News

National Pharmacy Week celebrated in India

The Indian Pharmaceutical Association in collaboration with Delhi Pharmaceutical Trust celebrated the 59th National Pharmacy Week between November 16, 2020 and November 22, 2020. The National Pharmacy Week was celebrated under the theme Theme: Pharmacists: Frontline Health Professionals The Indian Pharmaceutical Association has been organizing the National Pharmacy Week every year during the third week ..

Month: 

Category: 

Topics: 

November 17: National Epilepsy Day

Every year, the National Epilepsy Day is celebrated on November 17. The day is celebrated to create awareness about epilepsy. What is Epilepsy? Epilepsy is a chronic brain disorder. It results in recurrent fits or seizures. The seizures occur due to sudden and excessive discharges occurring in brain cells or neurons. The disease can be ..

Month: 

Category: 

Topics: 

GoI releases “Health in India” report

The Ministry of Statistics and Programme Implementation recently released a report titled “Health in India”. The main objective of the report was to gather quantitative information on India’s health sector. Highlights The report highlighted on health of religious communities in the country. Key Findings of the Report The report said that around 7.5% of Indians ..

Month: 

Category: 

Topics: 

GoI to increase public health care expenditure from 1.15% to 2.5% by 2025

On September 27, 2020, the Union Health Minister Dr Harsh Vardhan announced that Government of India is to increase the health care expenditure in the country by 2.5% of GDP by 2025. Currently, the government is spending 1.15% of GDP to fulfil health care needs. Highlights The increase is being done based on the recommendation ..

Month: 

Category: 

Topics: 

DCGI approves Favipiravir for treating COVID-19

The drugs controller general of India (DGCI) granted approval to Glenmark Pharmaceuticals to manufacture and market oral antiviral drug Favipiravir to treat mild and moderate COVID-19 cases in India. The drug will be marketed under the brand name ‘FabiFlu’. It is known to prevent the virus from replication. In Japan, the drug is sold under ..

Month: 

Topics: 

1 / 109123>>>